News - Medical and health professional investment - VC and PE investment business - Shenzhen Efung Investment Management Co. Ltd.

发布时间: 2026 - 08 - 26

Efung Honor | Efung Capital Secures Three Awards on Qimingpian's 2026 Mid-Year Equity Investment Ser

Recently, Qimingpian officially released its 2026 Mid-Year Equity Investment Series Institution Rankings. Efung Capital was honored on three prestigious lists:Top 50 Most Active Venture Capital Institutions in ChinaTop 50 Comprehensive Venture Capital Institutions in ChinaTop 20 Investment Institutions in the Healthcare SectorIn the first half of 2026, China's equity investment market demonstrated a pattern of structural recovery alongside ongoing adjustments, with overall vitality continuing to release. Fundraising showed notable improvement, with both the number and scale of newly raised...

浏览次数：6

查看详情>>

发布时间: 2026 - 08 - 25

Efung Capital's Dr. Zhu Jinqiao Invited to Attend the 2026 Global Unicorn Summit

PrefaceWhen 1,603 unicorns worldwide, with a total value of RMB 54 trillion, converge on a single list, Hong Kong—the "super connector" city—ushered in the grand opening of the 2026 Global Unicorn Summit.01 Global Gathering, Hong Kong Kicks OffFrom August 24 to 25, the Global Unicorn Summit, hosted by Hong Kong Ta Kung Wen Wei Media Group, was held at the Hong Kong Convention and Exhibition Centre. Under the core theme "BORN TO LEAD, BUILT TO CREATE," the Summit leveraged Hong Kong as a launchpad to reach out to the world, bringing together global innovation forces across t...

浏览次数：8

查看详情>>

发布时间: 2026 - 08 - 21

Efung Honor | Efung Capital Named to [Jiazi Guangnian] 2025-2026 Top 30 Best Healthcare Investment I

On August 20, 2026, Jiazi Guangnian hosted the "Rapids – 2026 Jiazi Gravity X · Technology Industry Investment Conference," where the "2025-2026 China Technology Industry Investment Rankings" were officially released. Efung Capital was honored with the title of 2025-2026 Top 30 Best Healthcare Investment Institutions.In 2026, China's technology investment landscape is navigating new "rapids."Artificial intelligence is accelerating the reshaping of the industrial landscape, with hard tech remaining a core focus of capital. At the same time, valuation syste...

浏览次数：5

查看详情>>

发布时间: 2026 - 08 - 19

Efung News | NDA for Progen's Recombinant Human Serum Albumin Injection Formally Accepted by NMPA

August 18, 2026 – The New Drug Application (NDA) for Progen's independently developed Recombinant Human Serum Albumin Injection (rHSA, indicated for the treatment of cirrhotic ascites) has been formally accepted by the Center for Drug Evaluation (CDE) of the National Medical Products Administration (NMPA).This acceptance marks the entry of the product's review and approval process into the substantive stage, and represents another key milestone for Progen in its path of independent innovation and industrialization of recombinant protein therapeutics.Feng Capital participated in Progen&...

浏览次数：7

查看详情>>